Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
2022;117(10S):44-52
However, another study found a significantly lowered risk of developing glaucoma and ocular hypertension in all patient groups receiving the treatment at 1, 2, and 3 years (41%, 50%, and 41% risk reduction, respectively) (Muayad et al., 2024)
Tumor delivery and in vivo processing of disulfide-linked and thioether-linked antibodymaytansinoid conjugates
A combination may provide better blood sugar control and reduce side effects more than a higher dose of a single drug
US$ 28.87
US$ 27.37
US$ 23.15
US$ 21.80
US$ 27.66
US$ 20.33
